Fabrazyme (agalsidase beta) Market Insight: Market Trends, Growth, Forecasted from 2024 TO 2031

Market Overview and Report Coverage Fabrazyme (agalsidase beta) is an enzyme replacement therapy used to treat Fabry disease, a rare genetic disorder that affects the kidneys, heart, and nervous system. The drug works by replacing the missing enzyme ...